1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

09 Oct 2023
Admin
News Article

BiomX Completes Patient Dosing in Phase 1b/2a Study for BX004 in Cystic Fibrosis

BiomX has announced the successful completion of patient dosing in the second part of its
phase 1b/2a clinical trial assessing BX004, a novel treatment aimed at addressing chronic
pulmonary infections resulting from Pseudomonas aeruginosa in individuals diagnosed with
cystic fibrosis (CF).

BX004 has been specifically developed to address a pressing unmet medical need affecting
numerous cystic fibrosis (CF) patients who are in dire need of innovative therapies to combat
persistent and life-threatening lung infections.

This novel treatment has been created using BiomX's proprietary BOLT platform, with the
primary goal of addressing chronic pulmonary infections caused by Pseudomonas aeruginosa
(P. aeruginosa), a leading contributor to the morbidity and mortality observed in CF patients.

The phase 1b/2a trial for BX004 consists of two distinct parts. Part 1 of the study has reported
positive outcomes, focusing on the assessment of safety, pharmacokinetics, as well as
microbiologic and clinical activity. This part involved nine CF patients and followed a single
ascending dose and multiple dose design.

Part 2 of the trial is set to evaluate the safety and efficacy of BX004 in a larger cohort, involving
at least 24 CF patients who will be randomly assigned to either a treatment or placebo group in a
2:1 ratio.

In August 2023, the FDA granted BX004 fast track designation for its potential in treating
chronic respiratory infections caused by Pseudomonas aeruginosa (PsA) bacterial strains in CF
patients.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!